The Challenge of Drug-Resistant Organisms

When antibiotics first arrived in the 1940s, they revolutionized medicine and saved countless lives. But today, healthcare professionals face a growing crisis: bacteria that refuse to die. These drug-resistant organisms, sometimes called “superbugs,” have developed clever ways to survive even our strongest medications. Understanding how these organisms develop resistance and what we’re doing to combat them is crucial for anyone working in healthcare.

What are drug-resistant organisms? 🔗

Drug-resistant organisms are bacteria that have evolved the ability to withstand antibiotics designed to kill them. The Centers for Disease Control and Prevention defines antimicrobial resistance (AMR) as occurring when germs like bacteria develop the ability to defeat the drugs designed to kill them. This means infections become difficult, sometimes impossible, to treat.

The problem is staggering in scale. The World Health Organization reports that bacterial AMR was directly responsible for 1.27 million deaths in 2019 and contributed to nearly five million deaths globally. In the United States alone, more than 2.8 million antimicrobial-resistant infections occur each year, resulting in over 35,000 deaths.

How bacteria develop resistance 🔗

Bacteria don’t develop resistance to spite us. Rather, resistance is a natural survival mechanism that accelerates when bacteria are exposed to antibiotics. When you take an antibiotic, it kills most bacteria causing your infection. However, some bacteria may have random genetic mutations that help them survive. These survivors multiply and pass their resistance traits to other bacteria.

From an evolutionary perspective, bacteria use two major genetic strategies to adapt: mutations in genes associated with the antibiotic’s mechanism of action, and acquisition of foreign DNA coding for resistance determinants through horizontal gene transfer. This means bacteria can not only inherit resistance from parent cells but also share resistance genes with completely different bacterial species.

The mutation factor 🔗

Bacteria have remarkably high mutation rates. Every time a bacterial cell divides, there’s a chance for genetic changes. Most mutations harm the bacteria, but occasionally one provides an advantage. Bacteria have an average mutation rate of one for every 106 to 109 cell divisions, creating constant opportunities for resistance to emerge.

Main mechanisms of antibiotic resistance 🔗

Bacteria employ several sophisticated strategies to defeat antibiotics. Understanding these mechanisms helps researchers develop new treatment approaches.

Restricting drug access 🔗

Some bacteria prevent antibiotics from reaching their targets by changing the structure of their cell walls. Gram-negative bacteria have an outer membrane that protects them from their environment, which they can use to selectively keep antibiotic drugs from entering. Think of it as locking the doors before an unwelcome visitor arrives.

Pumping drugs out 🔗

Bacteria can produce pumps that sit in their membrane or cell wall, transporting antibiotics out from the bacterial cell and lowering the antibiotic concentration inside. These efflux pumps work continuously, ensuring the antibiotic never reaches lethal levels inside the bacterial cell.

Destroying or modifying antibiotics 🔗

Perhaps the most direct approach is simply destroying the antibiotic itself. Klebsiella pneumoniae bacteria produce enzymes called carbapenemases, which break down carbapenem drugs and most other beta-lactam drugs. Other bacteria add chemical groups to antibiotics, preventing them from binding to their targets.

Changing the target 🔗

Antibiotics work by binding to specific targets in bacterial cells. When bacteria modify these targets, the antibiotic can no longer attach and do its job. Examples include the alteration of penicillin-binding proteins in MRSA and other penicillin-resistant bacteria. The antibiotic arrives at its destination only to find the locks have been changed.

The global burden of resistance 🔗

The statistics paint a sobering picture of our current situation. Recent surveillance data reveals the problem is accelerating. According to WHO’s latest surveillance report, antibiotic resistance rose in more than 40 percent of the bacteria-drug combinations tracked between 2018 and 2023, with average annual increases ranging from 5 to 15 percent.

The impact varies by region. One in three infections in WHO’s South-East Asia and Eastern Mediterranean regions were resistant to antibiotics, compared with one in five in Africa. Particularly concerning are Gram-negative bacteria like Escherichia coli and Klebsiella pneumoniae, which show alarming resistance levels to first-line treatments.

Economic and healthcare impacts 🔗

Infections caused by multidrug-resistant organisms are associated with increased mortality compared to those caused by susceptible bacteria, and they carry an important economic burden, estimated at over 20 billion dollars per year in the United States alone. Looking ahead, projections are even more troubling. Without intervention, antibiotic-resistant infections could cause around 300 million premature deaths by 2050.

Fighting back: New antibiotic development 🔗

The medical community isn’t standing still. Researchers worldwide are pursuing innovative strategies to develop new antibiotics that can overcome resistance mechanisms.

Artificial intelligence in drug discovery 🔗

Machine learning is revolutionizing antibiotic discovery. Researchers at MIT and McMaster University used an artificial intelligence algorithm to identify a new antibiotic that can kill Acinetobacter baumannii, a bacteria responsible for many drug-resistant infections. This AI-driven approach can screen millions of compounds in hours, dramatically accelerating the discovery process.

Using generative AI algorithms, research teams designed more than 36 million possible compounds and computationally screened them for antimicrobial properties. The top candidates discovered are structurally distinct from any existing antibiotics and appear to work by novel mechanisms.

Novel antibiotic classes 🔗

Several promising new antibiotics are in development. Researchers developed a fully synthetic compound called cresomycin that works in both gram-positive and gram-negative bacteria. When tested in mice with antibiotic-resistant infections, all treated mice survived, while most untreated mice died within two days.

Scientists from Harvard University and Roche developed zosurabalpin, a new antibiotic that can effectively kill Acinetobacter baumannii through a unique method of action. The antibiotic belongs to its own chemical class and works differently from any existing drugs.

The challenge ahead 🔗

Despite scientific progress, significant obstacles remain. The commercial market for new antibiotics is challenging because these drugs are intentionally held in reserve to prevent resistance from developing. A new antibiotic often costs more than one billion dollars to develop, but reluctance to use it widely means it is likely to earn less than 100 million dollars a year once on the market.

Success requires a comprehensive approach beyond just developing new drugs. This includes improving infection prevention and control, enhancing surveillance systems, promoting appropriate antibiotic use, and ensuring equitable access to both existing and new treatments. Healthcare workers play a crucial role in this effort through proper prescribing practices and patient education.

What do you think? How can healthcare professionals balance the immediate need to treat infections with the long-term goal of preventing resistance? What role should nurses play in educating patients about antibiotic resistance and appropriate medication use?

References

1. https://www.cdc.gov/antimicrobial-resistance/about/index.html
2. https://www.who.int/health-topics/antimicrobial-resistance
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC4888801/
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC6604941/
5. https://www.reactgroup.org/toolbox/understand/antibiotic-resistance/resistance-mechanisms-in-bacteria/
6. https://www.britannica.com/science/antibiotic-resistance
7. https://news.un.org/en/story/2025/10/1166087
8. https://news.mit.edu/2023/using-ai-scientists-combat-drug-resistant-infections-0525
9. https://news.mit.edu/2025/using-generative-ai-researchers-design-compounds-kill-drug-resistant-bacteria-0814
10. https://www.nih.gov/news-events/nih-research-matters/designing-new-antibiotic-combat-drug-resistance
11. https://www.cnn.com/2024/01/03/health/new-antibiotic-drug-resistant/index.html
12. https://www.nature.com/articles/d41586-023-04086-z